We report a non-enzymatic electrochemical sensing platform for creatinine based on a nickel-nanoparticle/carbon-quantum-dot (NiNP–CQD) hybrid interface. In this system, the analytical signal originates from the direct electrocatalytic oxidation of creatinine mediated by the Ni(II)/Ni(III) redox couple (Ni(OH)2/NiOOH), which forms during electrochemical activation of nickel in alkaline media. These redox centers act as catalytic sites that oxidize creatinine without requiring enzymes or biomolecular labels. The CQDs provide a conductive sp2-rich network with abundant oxygenated groups that promote homogeneous nucleation and dispersion of NiNPs, enhancing both surface area and electron-transfer efficiency. Electrochemical characterization of the modified electrodes was performed using the ferricyanide/ferrocyanide redox couple as the electron-transfer probe. Structural and microscopic characterization confirms uniform NiNP deposition on the CQD layer, while electrochemical studies demonstrates that the composite outperforms CQDs or NiNPs alone in current density, linearity, and resistance to active-site saturation. The resulting sensor exhibits a wide linear range (10–1000 µM), high area-normalized sensitivity (1.41 µA µM−1 cm−2), and a low detection limit of 5 µM. Selectivity tests reveal minimal interference from common physiological species. By explicitly leveraging a catalyst-driven, enzyme-free oxidation pathway, this NiNP–CQD architecture provides a robust, stable, and scalable platform for clinically relevant creatinine detection.
Osuna et al. (2025) studied this question.